Akebia Therapeutics
In David Abrams's portfolio · Abrams Capital Management
Ticker AKBA
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Abrams Capital Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q4 2020 | Sell | 0 | |
| Q3 2020 | No change | 5,656,462 | 0.4% |
| Q2 2020 | No change | 5,656,462 | 2.5% |
| Q1 2020 | No change | 5,656,462 | 1.7% |
| Q4 2019 | No change | 5,656,462 | 1.1% |
| Q3 2019 | No change | 5,656,462 | 0.6% |
| Q2 2019 | No change | 5,656,462 | 0.7% |
| Q1 2019 | No change | 5,656,462 | 1.3% |
| Q4 2018 | Add 405% | 5,656,462 | 1.3% |
| Q3 2018 | Buy | 1,119,286 | 0.3% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.